Resolute Advisors’s Abiomed Inc ABMD Stock Holding History

Resolute Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15	Closed	-$4K	–	508
2021 Q1	$4K	Buy	+15	New	+$4.8K	﹤0.01%	378

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Resolute Advisors's ABMD Position: Q2 2021 in Review

Resolute Advisors sold out of Abiomed Inc (ABMD) in Q2 2021, closing a stake of 15 shares — an estimated $4K sold.

Resolute Advisors first reported a position in ABMD in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 474 funds tracked by Wall St. Rank hold ABMD as of Q2 2021.

Resolute Advisors reported no remaining Abiomed Inc position as of Q2 2021 after selling out during the quarter.
Resolute Advisors sold 15 Abiomed Inc shares in Q2 2021, an estimated $4K.
Resolute Advisors first reported a position in Abiomed Inc in Q1 2021 and held it in 1 quarter.
Resolute Advisors's Abiomed Inc position peaked at $4K in Q1 2021.
474 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2021.

Based on Resolute Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.